Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Klebsiella pneumoniae

Identifiers: BioSample: SAMN35159627; Sample name: BWH_396_K_pne; SRA: SRS17748701

Organism: Klebsiella pneumoniae
cellular organisms; Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_396_K_pne
collected by	Brigham and Women's Hospital
collection date	2022
geographic location	USA:Boston
host	Homo sapiens
host disease	Wound infection
isolation source	wound
latitude and longitude	42.3362 N 71.1067 W
host age	65

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2023-05-18

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amoxicillin-clavulanic acid	resistant	>=	32/16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefoxitin	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftriaxone	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
doxycycline	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ertapenem	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
erythromycin	intermediate	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	susceptible	<=	0.12	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
linezolid	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	intermediate	==	64.0/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	1/19	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
vancomycin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN35159627
ID:: 35159627

BioProject SRA Nucleotide

BioSample

National Center for Biotechnology Information

Result Filters

Send to:

Pathogen: clinical or host-associated sample from Klebsiella pneumoniae

Supplemental Content

Related information

Recent activity